-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Progyny, Raises Price Target to $38

Benzinga·11/05/2026 19:59:52
Listen to the news
Leerink Partners analyst Michael Cherny maintains Progyny (NASDAQ:PGNY) with a Outperform and raises the price target from $37 to $38.